CTBE

TECHNOLOGY

What is an ACL injury?

The ACL is a band of dense connective tissue that runs from the thighbone to shinbone and plays an important role in stabilizing the knee joint. ACL injuries generally involve a tear or sprain of the ACL and often happen during sports such as soccer, basketball, football and skiing.

Problems of current ACL treatment

The standard treatment is to collect the patient's hamstring tendon or patellar tendon, make a graft, and implant it in the knee joint using arthroscopy. However, because this treatment method requires collecting patient’s healthy tissue, there is a risk of infection and decreased motor function. In addition, patients with re-rupture, or those with multiple ligament ruptures, may not have sufficient autologous tendons for transplant.

Therefore, an alternative treatment is needed to repair ACL injury.

tech

Solving conventional therapeutic challenges using proprietary decellularization technology

We are developing an artificial ligament for anterior cruciate ligament (ACL) reconstruction surgery by applying a proprietary "decellularization technology" to animal tissue to remove the cellular components that may cause rejection from living tissues. This approach makes it possible to develop products that have biocompatibility and strength as artificial ligaments.

While there are currently approximately 40 medical devices that use decellularized animal / human tissues on the market, all are made from thin films or thin tissues. We are aiming to commercialize the world's first artificial ligament that offers thickness and strength with decellularized animal tissue.

This makes it possible to develop products that have biocompatibility and strength as artificial ligaments.

In the market, there are about 40 medical devices that use decellularized animal / human tissues, but all of them are made from thin films or thin tissues. We are aiming to commercialize the world's first artificial ligament that requires thickness and strength with decellularized animal tissue.

TOP